多囊卵巢综合征氧化应激及标志物的研究进展

摘要
图/表
参考文献(24)
相关文章 (15)

全文: PDF (631 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要多囊卵巢综合征（PCOS）作为最常见的生殖内分泌失调性疾病，影响了5%~10%的育龄期女性。近年来尽管对PCOS的研究层出不穷，但其病因尚不明确。氧化应激在PCOS的病理生理学中扮演重要角色。PCOS患者细胞内活性氧的产生，受高度复杂的抗氧化酶和非酶系统控制。因此，了解氧化应激的机制对于预防和治疗PCOS具有重要意义。本文对PCOS氧化应激机制及相关标志物进行论述。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张晗吴林玲闫颖

关键词 ：多囊卵巢综合征, 氧化应激, 氧化标志物, 抗氧化剂

Abstract：Polycystic ovary syndrome(PCOS) is one of the most common hormonal disorders, occurring in 5%-10% women in reproductive ages. Although there are many researches on PCOS in recent years, its etiology is still unclear. Oxidative stress plays an important role in the pathophysiology of PCOS. Intracellular reactive oxygen species production in patients with PCOS is controlled by highly complex antioxidant enzymatic and non-enzyme systems. Therefore, understanding the mechanism of oxidative stress is of great significance for the prevention and treatment of PCOS. The oxidative stress mechanism and related markers of PCOS are discussed in this paper.

Key words： Polycystic ovary syndrome Oxidative stress Oxidation markers Antioxidants

基金资助:天津市教委科研计划项目（2018KJ019）；
天津市卫生健康委员会、天津市中医药管理局中医中西医结合科研课题（2019058）；
国家中医药管理局中医学术流派传承工作室建设项目-天津哈氏妇科流派传承工作室。

通讯作者: 闫颖（1973-），女，博士，主任医师，主要从事生殖内分泌研究工作。

作者简介: 张晗（1985-），女，博士，主要从事生殖内分泌研究工作。

引用本文:

张晗吴林玲闫颖. 多囊卵巢综合征氧化应激及标志物的研究进展[J]. 中国医药导报, 2020, 17(5): 31-34.
ZHANG Han WU Linling YAN Ying. Advances in oxidative stress and oxidative markers in polycystic ovary syndrome. 中国医药导报, 2020, 17(5): 31-34.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2020/V17/I5/31

[1] Bañuls C，Rovira-Llopis S，Martinez de Marañon A，et al. Metabolic syndrome enhances endoplasmic reticulum，oxidative stress and leukocyte-endothelium interactions in PCOS [J]. Metabolism，2017，71：153-162.
[2] Usselman CW，Yarovinsky TO，Steele FE，et al. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome：role of the endothelin B receptor [J]. J Physiol，2019，597（11）：2853-2865.
[3] Crespo RP，Bachega TASS，Mendon?觭a BB，et al. An update of genetic basis of PCOS pathogenesis [J]. Arch Endocrinol Metab，2018，62（3）：352-361.
[4] 刘言薇，刘中勇.调脂Ⅰ号通过NOX/ROS-NF-κB通路对巨噬细胞氧化应激损伤的保护作用[J].时珍国医国药，2019，30（1）：29-32.
[5] Mohammadi M. Oxidative Stress and Polycystic Ovary Syndrome：A Brief Review [J]. Int J Prev Med，2019，10：86.
[6] Sarniak A，Lipińska J，Tytman K，et al. Endogenous mechanisms of reactive oxygen species（ROS）generation [J]. Postepy Hig Med Dosw（Online），2016，70：1150-1165.
[7] Shorakae S，Ranasinha S，Abell S，et al. Inter-related effects of insulin resistance，hyperandrogenism，sympathetic dysfunction and chronic inflammation in PCOS [J]. Clin Endocrinol（Oxf），2018，89（5）：628-633.
[8] Artimani T，Karimi J，Mehdizadeh M，et al. Evaluation of pro-oxidant-antioxidant balance（PAB）and its association with inflammatory cytokines in polycystic ovary syndrome（PCOS）[J]. Gynecol Endocrinol，2018，34（2）：148-152.
[9] Zhang Y，Zhao W，Xu H，et al. Hyperandrogenism and insulin resistance-induced fetal loss：evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome [J]. J Physiol，2019， 597（15）：3927-3950.
[10] Liu HL，Li TT，Yu AQ，et al. Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome [J]. BMC Endocr Disord，2019，19（1）：32.
[11] 范强，杨丽霞，薛燕芳，等.2型糖尿病氧化应激与单味中药干预研究[J].时珍国医国药，2017，28（7）：1718-1721.
[12] Ahmad R，Vaali-Mohammed MA，Elwatidy M，et al. Induction of ROS-mediated cell death and activation of the JNK pathway by a sulfonamide derivative [J]. Int J Mol Med，2019，44（4）：1552-1562.
[13] Maktabi M，Jamilian M，Asemi Z. Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles，Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome：a Randomized，Double-Blind，Placebo-Controlled Trial [J]. Biol Trace Elem Res，2018，182（1）：21-28.
[14] Bannigida DM，Shivananda Nayak B，Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS [J]. Arch Physiol Biochem，2018，17：1-4.
[15] Di Segni C，Silvestrini A，Fato R，et al. Plasmatic and Intracellular Markers of Oxidative Stress in Normal Weight and Obese Patients with Polycystic Ovary Syndrome [J]. Exp Clin Endocrinol Diabetes，2017，125（8）：506-513.
[16] Fatima Q，Amin S，Kawa IA，et al. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome （PCOS）：A case-control study [J]. Diabetes Metab Syndr，2019，13（3）：1957-1961.
[17] Krishna MB，Joseph A，Thomas PL，et al. Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome [J]. Cell Physiol Biochem，2017，43（5）：1880-1892.
[18] Garg D，Merhi Z. Relationship between advanced glycation end products and steroidogenesis in PCOS [J]. Reprod Biol Endocrinol，2016，14（1）：71.
[19] Isik H，Aynioglu O，Timur H，et al. Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors? [J]. J Reprod Immunol，2016，116：98-103.
[20] Yilmaz N，Inal HA，Gorkem U，et al. Follicular fluid total antioxidant capacity levels in PCOS [J]. J Obstet Gynaecol，2016，36（5）：654-657.
[21] Seleem AK，El Refaeey AA，Shaalan D，et al. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection [J]. J Assist Reprod Genet，2014，31（4）：499-504.
[22] Savic-Radojevic A，Bozic Antic I，Coric V，et al. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome [J]. Hormones（Athens），2015，14（1）：101-108.
[23] Sulaiman MA，Al-Farsi YM，Al-Khaduri MM，et al. Polycystic ovarian syndrome is linked to increased oxidative stress in Omani women [J]. Int J Womens Health，2018， 10：763-771.
[24] Savi■-Radojevi■ A，Ma?觩ibrada I，Djuki■ T，et al. Glutathione S-transferase （GST） polymorphism could be an early marker in the development of polycystic ovary syndrome （PCOS）-an insight from non-obese and non-insulin resistant adolescents [J]. Endokrynol Pol，2018，69（4）：366-374.